SV Investment Valuation Multiples

SV Investment is valued at $121M as of October 2026, a 7.4x revenue multiple. In the last fiscal year, SV Investment revenue was $16M and SV Investment EBITDA was ($333K).

SV Investment Overview

About SV Investment

SV Investment Corp operates as an Investment firm in South Korea. The company provides venture capital, initial public offer, merger and acquisition, operation consulting services and private equity investment services.


Founded

2006

HQ

South Korea

Employees

N/A

Sectors

Financials (Last FY)

Revenue: $16M
EBITDA: ($333K)

EV

$118M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SV Investment Financials

SV Investment reported last fiscal year revenue of $16M and negative EBITDA of ($333K).

In the same fiscal year, SV Investment generated $10M in gross profit, ($333K) in EBITDA losses, and had net loss of ($746K).


SV Investment P&L

In the most recent fiscal year, SV Investment reported revenue of $16M and EBITDA of ($333K).

SV Investment is unprofitable as of last fiscal year, with gross margin of 60%, EBITDA margin of (2%), and net margin of (5%).

See analyst estimates for SV Investment
Last FY202320242025202620272028
Revenue$16M$21M$17M$16M
Gross Profit$10M$17M$10M$9M
Gross Margin60%81%58%57%
EBITDA($333K)$5M($3M)($2M)
EBITDA Margin(2%)22%(18%)(10%)
EBIT Margin(13%)21%(20%)(19%)
Net Profit($746K)$3M($3M)($2M)
Net Margin(5%)14%(18%)(12%)
Net Debt$5M---

Financial data powered by Morningstar, Inc.

SV Investment Stock Performance

SV Investment has current market cap of $121M, and enterprise value of $118M.

Market Cap Evolution


SV Investment's stock price is $2.01.

SV Investment share price increased by 3.3% in the last 30 days, and by 72.6% in the last year.

SV Investment has an EPS (earnings per share) of $-0.01.

See more trading valuation data for SV Investment
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$118M$121M-0.0%3.3%63.7%72.6%$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SV Investment Valuation Multiples

SV Investment trades at 7.4x EV/Revenue multiple, and (353.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for SV Investment

SV Investment Financial Valuation Multiples

As of October 12, 2026, SV Investment has market cap of $121M and EV of $118M.

SV Investment has a P/E ratio of (161.9x).

Last FY202320242025202620272028
EV/Revenue7.4x5.5x6.8x7.4x
EV/EBITDAn/m25.6x(38.7x)(70.7x)
EV/EBIT(58.1x)26.9x(33.7x)(38.3x)
EV/Gross Profit12.2x6.8x11.7x12.9x
P/E(161.9x)39.8x(38.4x)(64.5x)
EV/FCF(125.4x)(20.0x)(49.4x)(119.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SV Investment Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SV Investment Margins & Growth Rates

In the most recent fiscal year, SV Investment reported gross margin of 60%, EBITDA margin of (2%), and net margin of (5%).

See estimated margins and future growth rates for SV Investment

SV Investment Margins

Last FY202420252026202720282029
Gross Margin60%58%57%60%
EBITDA Margin(2%)(18%)(10%)(2%)
EBIT Margin(13%)(20%)(19%)(13%)
Net Margin(5%)(18%)(12%)(5%)
FCF Margin(6%)(14%)(6%)(6%)

SV Investment Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth(19%)(8%)1%
Gross Profit Growth(41%)(10%)6%
EBITDA Growth(166%)(45%)(80%)
EBIT Growth(180%)(12%)(34%)
Net Profit Growth(204%)(40%)(60%)
FCF Growth(59%)(59%)(5%)

Data powered by FactSet, Inc. and Morningstar, Inc.

SV Investment Operational KPIs

SV Investment's Rule of 40 is (2%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SV Investment's Rule of X is (1%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for SV Investment
Last FY202320242025202620272028
Rule of 40(2%)---
Bessemer Rule of X(1%)---
S&M Expenses to Revenue10%9%10%10%
G&A Expenses to Revenue5%5%6%5%
Opex to Revenue113%79%120%119%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SV Investment Competitors

SV Investment competitors include Octopus AIM VCT, Tiny, Rbr Log FII, Inveo Yatirim Holding, Flerie, BOCOM Intl Hldgs Co, Morgan Stanley Emerg Mkts, Creal, Sparta Invest and Axon Partners.

Most SV Investment public comparables operate across PE & VC.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Octopus AIM VCT$5M-24.0x---
Tiny$143M$12M1.6x1.6x19.5x8.2x
Rbr Log FII$13M-3.1x---
Inveo Yatirim Holding$3M-69.8x---
Flerie-($79M)-10.0x(1.3x)(17.3x)
BOCOM Intl Hldgs Co$66M-2.0x---
Morgan Stanley Emerg Mkts$22M-6.3x---
Creal$239M$18M0.3x0.3x4.5x-

This data is available for Pro users. Sign up to see all SV Investment competitors and their valuation data.

Start Free Trial

Investments by SV Investment

SV Investment has invested in 74 companies to date.

Latest investment by SV Investment was on September 1st 2026. SV Investment invested in Inserasolution in their $10M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by SV Investment

Inserasolution
KaliVir Immunotherapeutics
LinqAlpha
CarbonSix
Description
-
KaliVir Immunotherapeutics is a clinical-stage biotechnology company developing oncolytic viral immunotherapies for solid tumors. The company's pipeline combines proprietary viral platforms with licensed technology from the University of Pittsburgh to create candidates that harness viral replication and immune activation against cancer.
LinqAlpha is a Boston-based generative AI platform designed for hedge fund equity research. It equips analysts with specialized search models to query financial filings, earnings transcripts, and market data from sources like SEC EDGAR and Bloomberg. Used by top multi-billion-dollar funds, it automates summarization of 10-Ks, peer comparisons, and event-driven signals to shorten research cycles.
CarbonSix is a Pittsburgh-based robotics company developing AI-driven robotic arms for bin picking and kitting in automotive assembly lines and electronics manufacturing. The systems integrate 3D vision, force sensing, and machine learning for high-speed handling of unstructured parts.
HQ CountrySouth KoreaUnited StatesUnited StatesSouth Korea
HQ City
Seongnam
Pittsburgh, PA
-
Seoul
Deal Date1 Sep 202619 Aug 20261 Jul 202630 Jun 2026
RoundSeries ASeries ASeries ASeries A
Raised$10M$14M$22M$40M
InvestorsL&S Venture Capital; SV Investment; InterVest Co.; SolidX; Innopolis Partners; Daekyo Investment; JB Ventures; Shinhan Venture InvestmentNextrans; SV Investment; Company K Partners; QUAD Investment Management; Flexus PartnersHana Ventures; AVP; NH Investment & Securities; Mirae Asset Venture Investment; SV Investment; NuVentures; YJ Capital; Betatron Venture Group; Samsung Securities; GFT Ventures; Mirae Asset Capital; Atinum InvestmentCortentia; Foothill Ventures; IMM Investment; DSC Investment; Storm Ventures; Zeitgeist Capital; CarbonBlack; Xquared VC; Korea Development Bank; SV Investment; LB Investment; ASQ
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all SV Investment investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SV Investment

When was SV Investment founded?SV Investment was founded in 2006.
Where is SV Investment headquartered?SV Investment is headquartered in South Korea.
Is SV Investment publicly listed?Yes, SV Investment is a public company listed on Korea Exchange.
What is the stock symbol of SV Investment?SV Investment trades under 289080 ticker.
When did SV Investment go public?SV Investment went public in 2018.
Who are competitors of SV Investment?SV Investment main competitors include Octopus AIM VCT, Tiny, Rbr Log FII, Inveo Yatirim Holding, Flerie, BOCOM Intl Hldgs Co, Morgan Stanley Emerg Mkts, Creal, Sparta Invest, Axon Partners.
What is the current market cap of SV Investment?SV Investment's current market cap is $121M.
What is the current revenue of SV Investment?SV Investment's last fiscal year revenue is $16M.
What is the current EV/Revenue multiple of SV Investment?Current revenue multiple of SV Investment is 7.4x.
Is SV Investment profitable?No, SV Investment is not profitable.
How many companies SV Investment has acquired to date?SV Investment hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SV Investment has invested to date?As of October 2026, SV Investment has invested in 74 companies.
What was the last SV Investment investment?On 1st September 2026 SV Investment invested in Inserasolution, participating in a $10M Series A round, alongside L&S Venture Capital, InterVest Co., SolidX, Innopolis Partners, Daekyo Investment, JB Ventures, and Shinhan Venture Investment.
In what companies SV Investment invested in?SV Investment invested in XCENA, GenEdit, MyRealTrip, Amogy, ABLY Corporation, SemiFive, PineTree Therapeutics, CarbonSix, SM Lab, Maka Motors, Asteromorph, Caring, Newracle Genetics, 3i, AITRICS, Above Golf Link, AGL, Swit, LinqAlpha, Innospace, and 54 other companies.

See public comps similar to SV Investment

Lists including SV Investment

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial